|
State Department |
|
|
Programme |
|
|
Sub Programme |
|
|
Allocation: |
KES 3,072,000,000.00 (R) |
Key Performance Indicators (Targets)
Key Output |
KPI |
Target Yr (2026) |
Target Yr (2027) |
Target Yr (2028) |
|---|---|---|---|---|
Medical Research Services |
Number of research Papers published |
600 |
650 |
700 |
Medical Research Services |
Number of Evidence/Policy briefs developed |
8 |
14 |
21 |
Medical Research Services |
Number of new trademarks/patents/copyrights filed |
4 |
4 |
4 |
Medical Research Services |
Number of Natural Products developed |
4 |
4 |
4 |
Medical Research Services |
Number of research projects completed |
70 |
77 |
87 |
Medical Research Services |
Number of commercializable Innovations Advanced to Prototype |
3 |
3 |
3 |
Medical Research Services
Number of research Papers published
2026
600
2027
650
2028
700
Medical Research Services
Number of Evidence/Policy briefs developed
2026
8
2027
14
2028
21
Medical Research Services
Number of new trademarks/patents/copyrights filed
2026
4
2027
4
2028
4
Medical Research Services
Number of Natural Products developed
2026
4
2027
4
2028
4
Medical Research Services
Number of research projects completed
2026
70
2027
77
2028
87
Medical Research Services
Number of commercializable Innovations Advanced to Prototype
2026
3
2027
3
2028
3
Previous Year Allocations
Num |
Year |
Total |
|---|---|---|
1 |
KES 3,072,000,000.00 |
|
2 |
KES 2,689,276,000.00 |
|
3 |
KES 2,508,950,000.00 |
|
4 |
KES 3,307,000,000.00 |
User Uploads
Percentage completion rate of human vaccine fill-and-finish facility Phase 1A (Engineering and Enabling works): 70
(2026)
Number of technology transfers agreements: 1
(2026)
Number of specialized laboratory tests undertaken: 1320000
(2026)